Cargando…

Parotid metastases from primary lung cancer: Case series and systematic review of the features

Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rulan, Wang, Ting, Zhou, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453833/
https://www.ncbi.nlm.nih.gov/pubmed/36091176
http://dx.doi.org/10.3389/fonc.2022.963094
_version_ 1784785227432853504
author Wang, Rulan
Wang, Ting
Zhou, Qinghua
author_facet Wang, Rulan
Wang, Ting
Zhou, Qinghua
author_sort Wang, Rulan
collection PubMed
description Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important. However, current studies about this issue are mostly case reports, and little is known about the detailed and systematic aspects. We reported three cases of parotid metastases from lung cancer and then systematically searched similar cases through “Pub-Med” and “Web of Science”. Finally, twenty-three patients were included in the study. Eighty-three percent of which were males, and 19 patients were over 50 years old. In all cases with smoking history mentioned, 93% were smokers. The predominant pathological type was small cell lung cancer (SCLC, 13 patients, 56%). Seventeen combined with other site metastasis, while more than half of which were brain metastases. The survival time ranged from 3months-17years, and as for SCLCs, it was only 3months-40months. It can be concluded that clinical features, such as sex, age, smoking history, pathological types, and metastasis patterns, could provide valuable evidence for diagnosis. The lung seems to be the most common primary site of parotid metastases except for head and neck tumors. The two circumstances, SCLC coexisting with Warthin’s tumor and parotid small cell carcinoma with lung metastasis, should be differentiated from parotid metastasis of lung cancer with caution For cases presented as SCLC, more aggressive strategies, such as chemotherapy with immunotherapy and maintenance therapy, may be more suitable. Due to the greater tendency of brain metastasis in such diseases, whole-brain radiation therapy, stereotactic radiosurgery or prophylactic cranial irradiation should be applied to corresponding patients in time. Additionally, lung cancer parotid metastases may be a marker of poor prognosis.
format Online
Article
Text
id pubmed-9453833
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94538332022-09-09 Parotid metastases from primary lung cancer: Case series and systematic review of the features Wang, Rulan Wang, Ting Zhou, Qinghua Front Oncol Oncology Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important. However, current studies about this issue are mostly case reports, and little is known about the detailed and systematic aspects. We reported three cases of parotid metastases from lung cancer and then systematically searched similar cases through “Pub-Med” and “Web of Science”. Finally, twenty-three patients were included in the study. Eighty-three percent of which were males, and 19 patients were over 50 years old. In all cases with smoking history mentioned, 93% were smokers. The predominant pathological type was small cell lung cancer (SCLC, 13 patients, 56%). Seventeen combined with other site metastasis, while more than half of which were brain metastases. The survival time ranged from 3months-17years, and as for SCLCs, it was only 3months-40months. It can be concluded that clinical features, such as sex, age, smoking history, pathological types, and metastasis patterns, could provide valuable evidence for diagnosis. The lung seems to be the most common primary site of parotid metastases except for head and neck tumors. The two circumstances, SCLC coexisting with Warthin’s tumor and parotid small cell carcinoma with lung metastasis, should be differentiated from parotid metastasis of lung cancer with caution For cases presented as SCLC, more aggressive strategies, such as chemotherapy with immunotherapy and maintenance therapy, may be more suitable. Due to the greater tendency of brain metastasis in such diseases, whole-brain radiation therapy, stereotactic radiosurgery or prophylactic cranial irradiation should be applied to corresponding patients in time. Additionally, lung cancer parotid metastases may be a marker of poor prognosis. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9453833/ /pubmed/36091176 http://dx.doi.org/10.3389/fonc.2022.963094 Text en Copyright © 2022 Wang, Wang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Rulan
Wang, Ting
Zhou, Qinghua
Parotid metastases from primary lung cancer: Case series and systematic review of the features
title Parotid metastases from primary lung cancer: Case series and systematic review of the features
title_full Parotid metastases from primary lung cancer: Case series and systematic review of the features
title_fullStr Parotid metastases from primary lung cancer: Case series and systematic review of the features
title_full_unstemmed Parotid metastases from primary lung cancer: Case series and systematic review of the features
title_short Parotid metastases from primary lung cancer: Case series and systematic review of the features
title_sort parotid metastases from primary lung cancer: case series and systematic review of the features
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453833/
https://www.ncbi.nlm.nih.gov/pubmed/36091176
http://dx.doi.org/10.3389/fonc.2022.963094
work_keys_str_mv AT wangrulan parotidmetastasesfromprimarylungcancercaseseriesandsystematicreviewofthefeatures
AT wangting parotidmetastasesfromprimarylungcancercaseseriesandsystematicreviewofthefeatures
AT zhouqinghua parotidmetastasesfromprimarylungcancercaseseriesandsystematicreviewofthefeatures